Noxsano Inc. is developing a device to treat chronic wounds.
Noxsano has raised $800K in total funding. The most recent round was Series A. The last funding was announced in July 2022.
Noxsano's investors include Rev1 Ventures, Nashville Entrepreneur Center.
Noxsano is headquartered in Columbus, United States.
Noxsano Inc. is developing a device to treat chronic wounds.
Noxsano is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Noxsano — Funding & Investors." VCBacked, July 1, 2022, https://www.vcbacked.co/company/noxsano. Accessed August 14, 2026.
VCBacked. (2022). Noxsano — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/noxsano
{{cite web |title=Noxsano — Funding & Investors |url=https://www.vcbacked.co/company/noxsano |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated